Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8433
Reference
MSAN(2025)14
Name
Estradiol (Estradot®) 25 micrograms/24 hours, 37.5 micrograms/24 hours, 50 micrograms/24 hours, 75 micrograms/24 hours, and 100 micrograms/24 hours transdermal patches – Update
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Drug Shortages
Description
Estradiol (Estradot®) 25 micrograms/24hours and 50 micrograms/24hours transdermal patches will be out of stock until early May 2025.
Limited supplies of estradiol (Estradot®) 75 micrograms/24hours and 100 micrograms/24hours transdermal patches are available until early May 2025.
Estradiol (Estradot®) 37.5 micrograms/24hours transdermal patches will be out of stock from late-April until July 2025.
Alternative brands of estradiol patches (Evorel® and Estraderm MX®) across these strengths are available and can support a full uplift in demand.
FemSeven® (estradiol) transdermal patches (once weekly application) remain available and can support an uplift in demand.
Progynova® (estradiol) transdermal patches also remain available but cannot support an uplift in demand.
Serious Shortage Protocols (SSPs) for estradiol (Estradot®) 25 micrograms/24hours, 50 micrograms/24 hours, 75 micrograms/24 hours and 100 micrograms/24 hours transdermal patches were issued (see PCA(P)(2025)05, PCA(P)(2024)35, PCA(P)(2024)36 and PCA(P)(2024)37).
Contact Name
Contact Email
Contact Address
Created
2025-04-11 15:08:00
Click to go back to homepage